United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 6 minute read Auto and Transport Industry News Why Uxin’s latest $91.89m revenue report could reshape sentiment in China’s used-car sector Uxin reports non-GAAP EPS of $0.00 on $91.89M revenue, raises full-year outlook and launches Q3 guidance—see why investors are paying close attention. byPallavi MadhirajuSeptember 29, 2025